当前位置: 首页 > 期刊 > 《中国医学创新》 > 2016年第23期
编号:12955630
microRNA在纤维化疾病中的研究进展及与宫腔粘连疾病的关系(4)
http://www.100md.com 2016年8月15日 《中国医学创新》 2016年第23期
     [15] Pottier N,Maurin T,Chevalier B, et al.Identification of keratinocytegrowth factor as a target of micro RNA-155 in lung fibroblasts:implication in epithelial-mesenchymal interactions [J].PLoS One,2009,4(8):e6718.

    [16] Nana-Sinkam S P,Hunter M G,Nuovo G J,et al.Integrating theMicro RNome into the study of lung disease[J].Am J Respir Crit Care Med,2009,179(1):4-10.

    [17] Zhong X,Chung A C,Chen H Y,et al.miR21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes[J].Diabetologia,2013,56(3):663-674.

    [18] Dey N,Ghosh-Choudhury N,Kasinath B S,et al.TGF-β stimulated microRNA-21 utilizes PTEN to orchestrate AKT/m

    TORC1 signaling for mesangial cellhypertrophy and matrix expansion [J].PLoS One,2012,7(8):e42 316.

    [19] Maurer B,Stanczyk J,Jungel A,et al.Micro RNA-29,a key regulator of collagen expression in systemic sclerosis[J].Arthritis Rheum,2010,62(6):1733-1743.

    [20] Rebecca D,Abbott J.Review of intrauterine adhesions[J].The Journal of Minimally Invasive Gynecology,2010,17(5):555-569.

    [21]成九梅,靳琳,夏恩兰,等.雌孕激素受体及转化生长因子-β1在宫腔粘连发病机制中的作用[J].中国实用妇科与产科杂志,2006,211(9):539-541.

    (收稿日期:2016-01-18) (本文编辑:蔡元元), 百拇医药(刘艳媚 王祥珍)
上一页1 2 3 4